TABLE 2.
Correlation between CASZ1 methylation levels and clinicopathological characteristics of primary glioma patient (n = 139)
| CASZ1 methylation levels | |||
|---|---|---|---|
| Characteristics | Low levels | High levels | p‐Value |
| Age | |||
| ≥40 | 33 | 33 | 0.871 |
| <40 | 35 | 37 | |
| NA | 1 | 0 | |
| Gender | |||
| Male | 46 | 36 | 0.068 |
| Female | 23 | 34 | |
| WHO grade | |||
| WHO II | 15 | 45 | <0.001 |
| WHO III | 25 | 15 | |
| WHO IV | 29 | 10 | |
| Histopathology | |||
| O | 3 | 10 | <0.001 |
| A | 12 | 35 | |
| AO | 7 | 5 | |
| AOA | 9 | 5 | |
| AA | 9 | 5 | |
| GBM | 29 | 10 | |
Abbreviations: A, astrocytoma; AA, anaplastic astrocytoma; AO, anaplastic oligodendroglioma; AOA, anaplastic oligoastrocytoma; GBM, glioblastoma; NA, not available; O, oligodendroglioma.